MSD secures full approval for Keytruda’s use in MSI-high solid tumours
Pharmaceutical Technology
MARCH 30, 2023
billion in 2028. Earlier in March, the FDA shared a draft guidance on how to run clinical trials for the accelerated approval of cancer drugs. Earlier in March, the FDA shared a draft guidance on how to run clinical trials for the accelerated approval of cancer drugs.
52 
Let's personalize your content